Richard Godin/LinkedIn
Sep 15, 2026, 13:50
Richard Godin: Challenges in Diagnosing Homozygous Familial Hypercholesterolemia
Richard Godin, Global Medical Director at Regeneron, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of Clinical Lipidology, adding:
”Clinicians face important challenges when considering diagnosing their patients with homozygous familial hypercholesterolemia.
My friends and I are happy to share our thoughts on the topic in a recent article published in the journal of clinical lipidology.”
Title: Exploring current challenges in diagnosing homozygous familial hypercholesterolemia: Insights from the historical evolution of diagnostic criteria
Authors: Daniel Gaudet, Richard Godin, Robert S. Rosenson, Gerald F. Watts
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 15, 2026, 13:42Sujan Sivasubramaniyam: Three Decades of Progress for Children with Haemophilia in Morocco
-
Sep 15, 2026, 13:31Mohammed Alkhani: Challenging the Conventional Approach to Paget-Schroetter Syndrome
-
Sep 15, 2026, 13:29Shadi Tabibian: Three Years of Progress Toward Life Beyond Hemophilia
-
Sep 15, 2026, 13:24Randall Curtis: Very Rewarding Week as a Co-Author, With a New Article in Production
-
Sep 15, 2026, 12:55Christopher Cannon: Calcium Scoring for Better Cardiovascular Risk Assessment
-
Sep 15, 2026, 12:55Lisa Krishtul: A Little Time Can Save a Life
-
Sep 15, 2026, 12:46Wolfgang Miesbach: Blood Centres as Health Weather Stations
-
Sep 15, 2026, 12:40Ronald F. Feinberg: Insulin Resistance May Be an Overlooked Cardiovascular Risk Factor
-
Sep 15, 2026, 12:33Seyed Mehrab Safdari: Factor VII Padua and the Limits of FVII Activity